Eagle Pharmaceuticals, inc. (EGRX)

[Bickema]

Eagle Pharmaceuticals Signs Definitive Agreement to Acquire Arsia Therapeutics Marking Entry into Biosimilar Market

http://investor.eagleus.com/press-release/eagle-pharmaceuticals-signs-definitive-agreement-acquire-arsia-therapeutics-marking-en

Under the terms of the stock purchase agreement, Eagle will pay approximately $30 million at closing, $27.3 million of which will be paid in cash and $2.7 million of which will be paid in Eagle common stock. Eagle has also agreed to pay up to $48 million in additional payments upon the completion of certain milestones, for aggregate potential payments of $78 million.